Lexeo Therapeutics, Inc. Common Stock (LXEO) Revenue History
Lexeo Therapeutics, Inc. Common Stock (LXEO) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-12-31 | $1.66M |
| 2022-12-31 | $654.00K |
| 2023-12-31 | N/A |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How LXEO compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | $500.00K |
| MNOV | MediciNova Inc. | $409.66K |
| PLSE | Pulse Biosciences Inc | $350.00K |
| BNTC | Benitec Biopharma Inc. | $75.00K |
| INO | Inovio Pharmaceuticals Inc. | $65.34K |
These are five companies in the same sector as LXEO with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Lexeo Therapeutics, Inc. Common Stock Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("LXEO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LXEO | $4.88 | -3.56% | 0.51M |
| 3 | ||||
| 4 | ||||
| 5 |